Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
Financial Contrast: Unilever PLC (UL) and USANA Health Sciences (USNA)
USANA Health Sciences (NYSE: USNA) and Unilever PLC (NYSE:UL) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, analyst recommendations, valuation and profitabiliy.
Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
Profitability
This table compares USANA Health Sciences and Unilever PLC’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| USANA Health Sciences | 9.47% | 30.12% | 21.45% |
| Unilever PLC | N/A | N/A | N/A |
Insider and Institutional Ownership
44.1% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 8.4% of Unilever PLC shares are owned by institutional investors. 53.2% of USANA Health Sciences shares are owned by insiders. Comparatively, 1.0% of Unilever PLC shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Analyst Ratings
This is a breakdown of current ratings and price targets for USANA Health Sciences and Unilever PLC, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| USANA Health Sciences | 0 | 0 | 1 | 0 | 3.00 |
| Unilever PLC | 2 | 3 | 5 | 0 | 2.30 |
USANA Health Sciences presently has a consensus target price of $70.00, indicating a potential upside of 23.35%. Unilever PLC has a consensus target price of $26.00, indicating a potential downside of 54.29%. Given USANA Health Sciences’ stronger consensus rating and higher probable upside, research analysts plainly believe USANA Health Sciences is more favorable than Unilever PLC.
Volatility & Risk
USANA Health Sciences has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Unilever PLC has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500.
Dividends
Unilever PLC pays an annual dividend of $1.64 per share and has a dividend yield of 2.9%. USANA Health Sciences does not pay a dividend.
Valuation and Earnings
This table compares USANA Health Sciences and Unilever PLC’s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | EBITDA | Earnings Per Share | Price/Earnings Ratio | |
| USANA Health Sciences | $1.02 billion | 1.39 | $146.58 million | $3.86 | 14.70 |
| Unilever PLC | $62.97 billion | 2.54 | $11.26 billion | N/A | N/A |
Unilever PLC has higher revenue and earnings than USANA Health Sciences.
Summary
USANA Health Sciences beats Unilever PLC on 8 of the 13 factors compared between the two stocks.
USANA Health Sciences Company Profile
Unilever PLC Company Profile